{"id":"W2208304134","doi":"10.1182/blood.v122.21.5378.5378","title":"Induction Therapy With Cyclophosphamide, Bortezomib, and Dexamethasone (CyBorD) For Primary Plasma Cell Leukemia (pPCL)","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Plasma cell leukemia; Bortezomib; Internal medicine; Cyclophosphamide; Gastroenterology; Dexamethasone; Median follow-up; Plasma cell dyscrasia; Melphalan; Multiple myeloma; Surgery; Chemotherapy; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001766156,0.0001355164,0.0003816483,0.0002588338,0.0003709783,0.0002650869,0.0002050094,0.0001870538,0.001552729],"category_scores_gemma":[0.000320247,0.00009450605,0.0002175872,0.0003105901,0.0002380133,0.0001116153,0.0003000577,0.0003047652,0.0003587551],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007188774,"about_ca_system_score_gemma":0.0005405289,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008816747,"about_ca_topic_score_gemma":0.00203181,"domain_scores_codex":[0.9998384,0.00003069038,0.00001533725,0.00004565002,0.00002813769,0.00004176727],"domain_scores_gemma":[0.9997228,0.00005871173,0.00007034779,0.00001862083,0.00001733315,0.0001123246],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.005517727,0.0009606526,0.8487511,0.0003321293,0.0001191787,0.009218339,0.0002438476,0.0009899205,0.04146087,0.0001286248,0.001937925,0.09033962],"study_design_scores_gemma":[0.000608453,0.01417311,0.9287642,0.00007958805,0.0000837388,0.0359667,0.0001442644,0.0007770011,0.008325915,0.0001047677,0.01095809,0.00001410459],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945529,0.002131916,0.000479835,0.0001297108,0.00001896595,0.0001877014,0.0002698349,0.00003595222,0.002193238],"genre_scores_gemma":[0.9977868,0.0006640077,0.000418689,0.0001271026,0.00003334754,0.00005688427,0.0003938365,0.000003443091,0.0005159994],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001552729,"threshold_uncertainty_score":0.005215824,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0133084105670059,"score_gpt":0.241517969213551,"score_spread":0.2282095586465451,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}